Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

References for PMC Articles for PubMed (Select 20352112)


Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.

Vaccine. 2009 Nov 5;27(47):6512-21. doi: 10.1016/j.vaccine.2009.08.053. Epub 2009 Sep 1.


A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA.

Influenza Other Respir Viruses. 2007 May;1(3):105-12. doi: 10.1111/j.1750-2659.2007.00016.x.


Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.

Patel A, Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP.

Vaccine. 2009 May 18;27(23):3083-9. doi: 10.1016/j.vaccine.2009.03.023. Epub 2009 Apr 1.


Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H.

PLoS Med. 2009 Apr 21;6(4):e1000049. doi: 10.1371/journal.pmed.1000049. Epub 2009 Apr 21.


Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice.

Rao S, Kong WP, Wei CJ, Yang ZY, Nason M, Styles D, DeTolla LJ, Panda A, Sorrell EM, Song H, Wan H, Ramirez-Nieto GC, Perez D, Nabel GJ.

PLoS One. 2008;3(6):e2432. doi: 10.1371/journal.pone.0002432. Epub 2008 Jun 18. Erratum in: PLoS ONE. 2009;8. doi: 10.1371/annotation/5fbbf39a-fb47-4ce1-8069-acd830b3d41f. PLoS ONE. 2008;3(9). doi: 10.1371/annotation/b8b66a84-4919-4a3e-ba3e-bb11f3853755. Panda, Aruna [added].


Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, Chen LM, Donis RO, Compans RW.

PLoS One. 2009;4(3):e4667. doi: 10.1371/journal.pone.0004667. Epub 2009 Mar 2.


Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.

Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, Moos M Jr, Ye Z, Hancock K, Weiss CD.

J Virol Methods. 2008 Nov;153(2):111-9. doi: 10.1016/j.jviromet.2008.07.015. Epub 2008 Sep 4.


Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

Lalor PA, Webby RJ, Morrow J, Rusalov D, Kaslow DC, Rolland A, Smith LR.

J Infect Dis. 2008 Jun 15;197(12):1643-52. doi: 10.1086/588431.


Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus.

Wei CJ, Xu L, Kong WP, Shi W, Canis K, Stevens J, Yang ZY, Dell A, Haslam SM, Wilson IA, Nabel GJ.

J Virol. 2008 Jul;82(13):6200-8. doi: 10.1128/JVI.00187-08. Epub 2008 Apr 16.


Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.

Lo CY, Wu Z, Misplon JA, Price GE, Pappas C, Kong WP, Tumpey TM, Epstein SL.

Vaccine. 2008 Apr 16;26(17):2062-72. doi: 10.1016/j.vaccine.2008.02.047. Epub 2008 Mar 13.


Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.

Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ.

Science. 2007 Aug 10;317(5839):825-8.


Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans.

Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM.

J Virol. 2007 Oct;81(20):11139-47. Epub 2007 Aug 8.


Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.

Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR.

Hum Vaccin. 2007 Sep-Oct;3(5):157-64. Epub 2007 Mar 20.


Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.

Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL.

Emerg Infect Dis. 2007 Mar;13(3):426-35.


Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis.

Nefkens I, Garcia JM, Ling CS, Lagarde N, Nicholls J, Tang DJ, Peiris M, Buchy P, Altmeyer R.

J Clin Virol. 2007 May;39(1):27-33. Epub 2007 Apr 3.


Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.

Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, Mascola JR, Nabel GJ, Graham BS; VRC 007 Study Team.

Vaccine. 2007 May 16;25(20):4085-92. Epub 2007 Mar 7.


Controlling influenza virus replication by inhibiting its proton channel.

Pinto LH, Lamb RA.

Mol Biosyst. 2007 Jan;3(1):18-23. Epub 2006 Nov 22. Review.


Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

Kong WP, Hood C, Yang ZY, Wei CJ, Xu L, GarcĂ­a-Sastre A, Tumpey TM, Nabel GJ.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15987-91. Epub 2006 Oct 16.


Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K.

PLoS Med. 2006 Sep;3(9):e360.


Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells.

Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL.

J Virol. 2006 Aug;80(15):7469-80.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk